Supernus Pharmaceuticals (SUPN) Other financing activities (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted Other financing activities of $88,000 for Q2 2026, up 91.3% from $46,000 a year earlier but down 98.1% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Other financing activities (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Other financing activities at Supernus Pharmaceuticals was $5.49 million, up 15.2% year-over-year; for FY2025, it was $4.23 million, up 55.8% from FY2024.
- In prior years, Supernus Pharmaceuticals' Other financing activities was $2.72 million in FY2024 (+36.4%) and $1.99 million in FY2023.
- Quarterly Other financing activities has run from a low of $1,000 in Q2 2024 to a high of $4.56 million in Q1 2026 over five years.
- On a year-over-year basis, Other financing activities increased in four of the last six quarters, with growth averaging 38.3%.
- The strongest year-over-year quarter for Other financing activities in the past five years was Q1 2024, with growth of 201.1%; the weakest was Q2 2024, with a decline of 99.8%.
- According to Business Quant data, Other financing activities for the three prior quarters was $4.56 million (Q1 2026), $31,000 (Q4 2025) and $811,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Supernus Pharmaceuticals | 2.50 Bn | 1.16 Bn | 185.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 88,000.00 |
| Mar 31, 2026 | 4.56 Mn |
| Dec 31, 2025 | 31,000.00 |
| Sep 30, 2025 | 811,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Mar 31, 2025 | 3.34 Mn |
| Dec 31, 2024 | 987,000.00 |
| Sep 30, 2024 | 387,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 1.34 Mn |
| Sep 30, 2023 | 970,000.00 |
| Jun 30, 2023 | 575,000.00 |
| Mar 31, 2023 | 445,000.00 |
| Sep 30, 2013 | 29,000.00 |
| Jun 30, 2013 | 3.47 Mn |
| Mar 31, 2013 | 125,000.00 |
| Dec 31, 2012 | 3.16 Mn |
| Sep 30, 2012 | 16,000.00 |
| Jun 30, 2012 | 2.20 Mn |
| Mar 31, 2012 | 669,000.00 |
API Access
Supernus Pharmaceuticals Other financing activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();